Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older Patients

Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older... ORIGINAL ARTICLE Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older Patients Alvaro Sanabria, MD, MSc, PhD; Andre´ Lopes Carvalho, MD, PhD; Jose´ Guilherme Vartanian, MD, PhD; Jose´ Magrin, MD, PhD; Mauro Kasuo Ikeda, MD, PhD; Luiz Paulo Kowalski, MD, PhD Objectives: To validate the prognostic ability of the and 62.9% for a score of 0; 25.1% and 41.7% for a score Washington University Head and Neck Comorbidity In- of 1; 39.3% and 64.9% for a score of 2; and 19.5% and dex (WUHNCI) relative to 5-year survival in a cohort of 45.0% for a score of 3 or higher. Using the ACE-27, 54.4% older patients with head and neck cancer and to com- and 61.7% for a score of 0 (no comorbidity); 46.8% and pare it with that of the Adult Comorbidity Evaluation 27 61.7% for a score of 1 (mild comorbidity); 31.7% and (ACE-27). 51.6% for a score of 2 (moderate comorbidity); and 13.8% and 43.7% for a score of 3 (severe comorbidity). The C Design: Validation study. statistics were 0.641 for the NCI comorbidity index, 0.656 for the ACE-27, and 0.686 for the WUHNCI. Setting: Academic research. Conclusions: The WUHNCI http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Otolaryngology–Head & Neck Surgery American Medical Association

Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older Patients

Download PDF
5 pages

Loading next page...
 
/lp/american-medical-association/validation-of-the-washington-university-head-and-neck-comorbidity-JmgoI5HFUm

References (21)

Publisher
American Medical Association
Copyright
Copyright 2008 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6181
eISSN
2168-619X
DOI
10.1001/archotol.134.6.603
pmid
18559726
Publisher site
See Article on Publisher Site

Abstract

ORIGINAL ARTICLE Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older Patients Alvaro Sanabria, MD, MSc, PhD; Andre´ Lopes Carvalho, MD, PhD; Jose´ Guilherme Vartanian, MD, PhD; Jose´ Magrin, MD, PhD; Mauro Kasuo Ikeda, MD, PhD; Luiz Paulo Kowalski, MD, PhD Objectives: To validate the prognostic ability of the and 62.9% for a score of 0; 25.1% and 41.7% for a score Washington University Head and Neck Comorbidity In- of 1; 39.3% and 64.9% for a score of 2; and 19.5% and dex (WUHNCI) relative to 5-year survival in a cohort of 45.0% for a score of 3 or higher. Using the ACE-27, 54.4% older patients with head and neck cancer and to com- and 61.7% for a score of 0 (no comorbidity); 46.8% and pare it with that of the Adult Comorbidity Evaluation 27 61.7% for a score of 1 (mild comorbidity); 31.7% and (ACE-27). 51.6% for a score of 2 (moderate comorbidity); and 13.8% and 43.7% for a score of 3 (severe comorbidity). The C Design: Validation study. statistics were 0.641 for the NCI comorbidity index, 0.656 for the ACE-27, and 0.686 for the WUHNCI. Setting: Academic research. Conclusions: The WUHNCI

Journal

JAMA Otolaryngology–Head & Neck Surgery – American Medical Association

Published: Jun 1, 2008

There are no references for this article.